(1) Active and reserve military personnel. All active and reserve military
personnel entering active duty for periods in excess of 30 days are immunized against
influenza soon after entry on duty. An annual immunization against influenza is given,
except for those individuals who have received an identical composition vaccine during
the preceding 3 months. The annual immunization program commences in October in
the U.S., Europe, and the Far East.
(2) Compliance. The Army monitors the compliance with the influenza
immunization program. The vaccine is provided to all health care providers and others
considered to be at high risk for influenza infection.
f. Japanese B Encephalitis (JE). Specific guidance on indications for use and
schedule of immunization in military populations is provided by each Service.
g. Measles, Mumps, and Rubella (MMR).
(1) Measles and rubella. Measles and rubella are administered to all recruits
regardless of prior history. Measles and rubella antibody testing and selective
immunization is performed if cost-effective. Single virus vaccines can be used as
appropriate, if available.
(2) Mumps. Mumps or MMR vaccine is administered to persons considered
to be mumps susceptible. Written documentation of physician diagnosed mumps or a
documented history of prior receipt of live virus mumps vaccine or MMR vaccine is
adequate evidence of immunity.
(3) Health care workers. All military and civilian personnel engaged in the
delivery of health care and having patient contact are appropriately immunized against
measles, mumps, and rubella following current ACIP recommendations. Those born
before 1957 require laboratory evidence of immunity or written documentation of one
dose of measles-containing vaccine after one year of age.
h. Meningoccus. Quadrivalent meningococcal vaccine (containing A, C, Y, and
W-135 polysaccharide antigens) is administered on a one-time basis to recruits. The
vaccine is given as soon as practicable after in-processing or training. This vaccine is
required routinely only for recruits, although its use may be indicated in other situations
based on transmission potential and risk of contracting meningococcal disease. Service
preventive medicine authorities are contacted regarding indications for use beyond the
i. Plague. There is no requirement for routine immunization. Plague vaccine is
administered to personnel who are likely to be assigned to areas where the risk of
endemic transmission or other exposure is high. Vaccine may not be effective in the
prevention of airborne infection. The addition of antibiotic prophylaxis is recommended
for such situations.